This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Managing Sepsis and Septic Shock: Current Guidelines and Definitions. AJN 2018; 118(2):34-39.Managing Sepsis and Septic Shock: Current Guidelines and DefinitionsAJN20181182343910.1097/01.NAJ.0000530223.33211.f529329118Search in Google Scholar
Singer M, Deutschman CS, Seymour CW et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 2016; 315(8): 801-10.SingerMDeutschmanCSSeymourCWet alThe third international consensus definitions for sepsis and septic shock (Sepsis-3)JAMA201631588011010.1001/jama.2016.0287496857426903338Search in Google Scholar
Georgescu AM, Grigorescu BL, Chirteș IR, Vitin A, Fodor RS. The Relevance of Coding Gene Polymorphisms of Cytokines and Cellular Receptors in Sepsis. The Journal of Critical Care Medicine 2017;3(1):5-11.GeorgescuAMGrigorescuBLChirteșIRVitinAFodorRSThe Relevance of Coding Gene Polymorphisms of Cytokines and Cellular Receptors in SepsisThe Journal of Critical Care Medicine20173151110.1515/jccm-2017-0001576988829967864Search in Google Scholar
Georgescu AM, Banescu C, Badea I et al. IL-6 gene polymorphisms and sepsis in ICU adult romanian patients: a prospective study. Rev Romana Med Lab. 2017; 25(1):75-89.GeorgescuAMBanescuCBadeaIet alIL-6 gene polymorphisms and sepsis in ICU adult romanian patients: a prospective studyRev Romana Med Lab2017251758910.1515/rrlm-2016-0044Search in Google Scholar
Nargis W, Ibrahim MD, Ahamed BU. Procalcitonin versus C-reactive protein: Usefulness as biomarker of sepsis in ICU patient. Int J Crit Illn Inj Sci. 2014 Jul-Sep; 4(3): 195–199.NargisWIbrahimMDAhamedBUProcalcitonin versus C-reactive protein: Usefulness as biomarker of sepsis in ICU patientInt J Crit Illn Inj Sci2014Jul-Sep4319519910.4103/2229-5151.141356420054425337480Search in Google Scholar
Rauniyar K, Kumar Jha S, Jeltsch M. Biology of Vascular Endothelial Growth Factor C in the Morphogenesis of Lymphatic Vessels. Front Bioeng Biotechnol. 2018; 6: 7.RauniyarKKumarJha SJeltschMBiology of Vascular Endothelial Growth Factor C in the Morphogenesis of Lymphatic VesselsFront Bioeng Biotechnol20186710.3389/fbioe.2018.00007581623329484295Search in Google Scholar
S. Ramakrishnan, Anand V, Roy S.. Vascular Endothelial growth factor signalling in hypoxia and Inflammation. J Neuroimmune Pharmacol. 2014 Mar; 9(2): 142–160.RamakrishnanS.AnandVRoySVascular Endothelial growth factor signalling in hypoxia and InflammationJ Neuroimmune Pharmacol2014Mar9214216010.1007/s11481-014-9531-7404828924610033Search in Google Scholar
Adams RH, Alitalo K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol. 8(6): 464-478.AdamsRHAlitaloKMolecular regulation of angiogenesis and lymphangiogenesisNat Rev Mol Cell Biol8646447810.1038/nrm218317522591Search in Google Scholar
Azamfirei L, Gurzu S, Solomon R et al. Vascular endothelial growth factor: a possible mediator of endothelial activation in acute respiratory distress syndrome. Minerva Anestesiologica. 2010 August;76(8):609-16.AzamfireiLGurzuSSolomonRet alVascular endothelial growth factor: a possible mediator of endothelial activation in acute respiratory distress syndromeMinerva Anestesiologica2010August76860916Search in Google Scholar
Y. Zhang, Lu Y, Ma L et al. Activation of vascular endothelial growth factor receptor-3 in macrophages restrains TLR4-NF-κB signalling and protects against endotoxin shock. Immunity. 2014; 40:501–514.ZhangY.LuYMaLet alActivation of vascular endothelial growth factor receptor-3 in macrophages restrains TLR4-NF-κB signalling and protects against endotoxin shockImmunity20144050151410.1016/j.immuni.2014.01.01324656836Search in Google Scholar
Schorr C, Zanotti S, Dellinger RP. Severe sepsis and septic shock. Virulence. 2014 Jan 1; 5(1): 190–199.SchorrCZanottiSDellingerRPSevere sepsis and septic shockVirulence2014Jan 1;5119019910.4161/viru.27409391637324335487Search in Google Scholar
Yano K, Liaw PC, Mullington JM et al. Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality. J Exp Med. 2006 Jun 12; 203(6): 1447–1458.YanoKLiawPCMullingtonJMet alVascular endothelial growth factor is an important determinant of sepsis morbidity and mortalityJ Exp Med2006Jun 1220361447145810.1084/jem.20060375211832916702604Search in Google Scholar
Karlsson S, Pettila V, Tenhunen J et al. Vascular Endothelial Growth Factor in Severe Sepsis and Septic Shock. Anesth Analg, 2008;106:1820-1826.KarlssonSPettilaVTenhunenJet alVascular Endothelial Growth Factor in Severe Sepsis and Septic ShockAnesth Analg,20081061820182610.1213/ane.0b013e31816a643f18499616Search in Google Scholar
Tilea I, Popa DS, Xantus TSZ et al. Determination of Apixaban Levels in Human Plasma by a High-Throughput Liquid Chromatographic Tandem Mass Spectrometry Assay. Rev Romana Med Lab. 2015; 23(1):115-126.TileaIPopaDSXantusTSZet alDetermination of Apixaban Levels in Human Plasma by a High-Throughput Liquid Chromatographic Tandem Mass Spectrometry AssayRev Romana Med Lab201523111512610.1515/rrlm-2015-0006Search in Google Scholar
Namba S, Yamaoka-Tojo M, Kakizaki R et al. Efects on bone metabolism markers and arterial stifness by switching to rivaroxaban from warfarin in patients with atrial fibrillation. Heart Vessels. 2017; 32(8):977-982.NambaSYamaoka-TojoMKakizakiRet alEfects on bone metabolism markers and arterial stifness by switching to rivaroxaban from warfarin in patients with atrial fibrillationHeart Vessels201732897798210.1007/s00380-017-0950-228233091Search in Google Scholar
Varga A, Farczadi L, Vlase L et al. Liquid Chromatography Tandem Mass Spectrometry Simultaneous Determination of Amlodipine and Telmisartan in Human Plasma for Therapeutic Drug Monitoring. Rev Chim. 2015; 66(10):1675-1679.VargaAFarczadiLVlaseLet alLiquid Chromatography Tandem Mass Spectrometry Simultaneous Determination of Amlodipine and Telmisartan in Human Plasma for Therapeutic Drug MonitoringRev Chim2015661016751679Search in Google Scholar
Di Filippo L, Dos Santos KC, Hanck-Silva G et al. A Critical Review of Biological Properties, Delivery Systems and Analytical/ Bioanalytical Methods for Determination of Bevacizumab. Crit Rev Anal Them. 2020; 10.1080/10408347.2020.1743641.DiFilippo LDosSantos KCHanck-SilvaGet alA Critical Review of Biological Properties, Delivery Systems and Analytical/ Bioanalytical Methods for Determination of BevacizumabCrit Rev Anal Them202010.1080/10408347.2020.174364132295395Open DOISearch in Google Scholar
EL-Akabawy H, Hamela MA, Gaber A, Abozekry A. Prognostic value of vascular endothelial growth factor in sepsis syndrome. The Egyptian Journal of Critical Care Medicine 2016; 4:119126.EL-AkabawyHHamelaMAGaberAAbozekryAPrognostic value of vascular endothelial growth factor in sepsis syndromeThe Egyptian Journal of Critical Care Medicine2016411912610.1016/j.ejccm.2016.10.002Search in Google Scholar
Shapiro IN, Yano K, Okada H et al. A prospective, observational study of soluble FLT-1 and vascular endothelial growth factor in sepsis. Shock. 2008 Apr; 29(4): 452–457.ShapiroINYanoKOkadaHet alA prospective, observational study of soluble FLT-1 and vascular endothelial growth factor in sepsisShock2008Apr29445245710.1097/SHK.0b013e31815072c1537849418598002Search in Google Scholar
Raith EP, Udy AA, Bailey M et al. Prognostic accuracy of the SOFA score, SIRS criteria, and qSOFA score for in-hospital mortality among adults with suspected infection admitted to the intensive care unit. JAMA 2017; 317(3): 290-300.RaithEPUdyAABaileyMet alPrognostic accuracy of the SOFA score, SIRS criteria, and qSOFA score for in-hospital mortality among adults with suspected infection admitted to the intensive care unitJAMA2017317329030010.1001/jama.2016.2032828114553Search in Google Scholar
Zhang RY, Zhang H, Huang J, Qu HP, Tang YQ. Angiogenic factors in sepsis: are we ready for the new therapeutic era? Crit Care. 2014; 18(1): 403.ZhangRYZhangHHuangJQuHPTangYQAngiogenic factors in sepsis: are we ready for the new therapeutic era?Crit Care201418140310.1186/cc13710405643724476499Search in Google Scholar
